Loading...
Microba Life Sciences Limited
MAP.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$0.09
A$0.002(2.41%)
Microba Life Sciences Limited (MAP.AX) Financial Performance & Statements
Review Microba Life Sciences Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
123.06%
↑ 123.06%
Operating Income Growth
-32.71%
↓ 32.71%
Net Income Growth
-57.24%
↓ 57.24%
Operating Cash Flow Growth
-25.60%
↓ 25.60%
Operating Margin
-112.15%
↓ 112.15%
Gross Margin
8.93%
↑ 8.93%
Net Profit Margin
-86.43%
↓ 86.43%
ROE
-47.90%
↓ 47.90%
ROIC
-59.13%
↓ 59.13%
Microba Life Sciences Limited (MAP.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Microba Life Sciences Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $8.82M | $3.27M | $1.64M | $3.27M |
| Cost of Revenue | $12.99M | $7.68M | $935492.00 | $6.60M |
| Gross Profit | -$4.18M | -$4.41M | $700936.00 | -$3.33M |
| Gross Profit Ratio | -$0.47 | -$1.35 | $0.43 | -$1.02 |
| R&D Expenses | $3.64M | $7.19M | $3.71M | $5.80M |
| SG&A Expenses | $3.72M | $3.71M | $3.18M | $2.13M |
| Operating Expenses | $7.31M | $10.89M | $6.69M | $7.93M |
| Total Costs & Expenses | $20.31M | $18.57M | $7.63M | $14.53M |
| Interest Income | $503362.00 | $501366.00 | $236248.00 | $732419.00 |
| Interest Expense | $40350.00 | $28871.00 | $0.00 | $30366.00 |
| Depreciation & Amortization | $1.83M | $1.04M | $327665.00 | $893629.00 |
| EBITDA | -$6.61M | -$10.44M | -$6.82M | -$6.07M |
| EBITDA Ratio | -$0.75 | -$4.36 | -$4.17 | -$3.17 |
| Operating Income | -$11.49M | -$15.30M | -$7.15M | -$11.26M |
| Operating Income Ratio | -$1.30 | -$4.68 | -$4.37 | -$3.44 |
| Other Income/Expenses (Net) | $3.01M | $3.79M | $1.39M | $4.26M |
| Income Before Tax | -$8.48M | -$11.51M | -$5.76M | -$7.00M |
| Income Before Tax Ratio | -$0.96 | -$3.52 | -$3.52 | -$2.14 |
| Income Tax Expense | -$28302.00 | -$23002.00 | $11501.00 | $5643.00 |
| Net Income | -$8.45M | -$11.49M | -$5.74M | -$7.001M |
| Net Income Ratio | -$0.96 | -$3.51 | -$3.51 | -$2.14 |
| EPS | -$0.02 | -$0.03 | -$0.02 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.03 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $447.85M | $372.28M | $371.79M | $364.65M |
| Weighted Avg Shares Outstanding (Diluted) | $447.85M | $372.28M | $372.28M | $364.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan